Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy

Dermatol Online J. 2010 May 15;16(5):16.

Abstract

The occurrence of sarcoidosis during anti-TNF-alpha therapy has occasionally been published. We report the case of a psoriasis patient who developed pulmonary sarcoidosis during a cycle of therapy with infliximab.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Psoriatic / drug therapy*
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Male
  • Sarcoidosis, Pulmonary / chemically induced*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab